New Antimicrobial Resistance Accelerator Programme launched by the Innovative Medicines Initiative (IMI)
A new Antimicrobial Resistance (AMR) Accelerator Programme as part of new Calls for proposals was launched in July by the Innovative Medicines Initiative (IMI). Of the other topics launched in the Calls, many address brain disorders (e.g. Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression) and immune-mediated diseases (e.g. rheumatoid arthritis and lupus as well […]
